Cargando…

Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers

The association between oral bisphosphonate use and upper gastrointestinal cancer has been controversial. Therefore, we examined the association with esophageal and gastric cancer within the Kaiser Permanente, Northern California population. A total of 1,011 cases of esophageal (squamous cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogtmann, Emily, Corley, Douglas A., Almers, Lucy M., Cardwell, Chris R., Murray, Liam J., Abnet, Christian C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596624/ https://www.ncbi.nlm.nih.gov/pubmed/26445463 http://dx.doi.org/10.1371/journal.pone.0140180

Ejemplares similares

Oral bisphosphonates and colorectal cancer
por: Vogtmann, Emily, et al.
Publicado: (2017)

Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users
por: Ghirardi, Arianna, et al.
Publicado: (2013)

Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case–control study
por: Ghirardi, Arianna, et al.
Publicado: (2014)

Symptoms and Upper Gastrointestinal Mucosal Injury Associated with Bisphosphonate Therapy
por: Yamamoto, Kana, et al.
Publicado: (2019)

A Prospective Study of Vitamin and Mineral Supplement Use and the Risk of Upper Gastrointestinal Cancers
por: Dawsey, Sonja P., et al.
Publicado: (2014)

Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis
por: Grosso, Anthony, et al.
Publicado: (2009)

Bisphosphonates and Risk of Upper Gastrointestinal Cancer — A Case Control Study Using the General Practice Research Database (GPRD)
por: Wright, Ellen, et al.
Publicado: (2012)

Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data
por: Vinogradova, Yana, et al.
Publicado: (2013)

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
por: Lo, Joan C., et al.
Publicado: (2020)

Association of Azithromycin Use With Cardiovascular Mortality
por: Zaroff, Jonathan G., et al.
Publicado: (2020)

Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea
por: Jung, Sun-Young, et al.
Publicado: (2016)

Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink
por: Hicks, B M, et al.
Publicado: (2015)

The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study
por: Knopp-Sihota, Jennifer A, et al.
Publicado: (2013)

Comparison of Oral Microbiota Collected Using Multiple Methods and Recommendations for New Epidemiologic Studies
por: Yano, Yukiko, et al.
Publicado: (2020)

Elucidating the role of the gastrointestinal microbiota in racial and ethnic health disparities
por: Byrd, Doratha A., et al.
Publicado: (2020)

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
por: Eekman, Danielle A, et al.
Publicado: (2009)

Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011)

Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case–control studies using two primary-care databases
por: Vinogradova, Y, et al.
Publicado: (2013)

Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials
por: Dömötör, Zsuzsa Réka, et al.
Publicado: (2020)

Risks and benefits of bisphosphonates
por: Coleman, R E
Publicado: (2008)

Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study
por: Seo, Gi Hyeon, et al.
Publicado: (2015)

Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Derman, Richard, et al.
Publicado: (2009)

MicrobiomeGWAS: A Tool for Identifying Host Genetic Variants Associated with Microbiome Composition
por: Hua, Xing, et al.
Publicado: (2022)

Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran
por: Islami, F, et al.
Publicado: (2004)

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
por: Burden, A. M., et al.
Publicado: (2011)

Oral bisphosphonate compliance and persistence: a matter of choice?
por: Silverman, S. L., et al.
Publicado: (2010)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Determinants of Oral Bisphosphonate Use Beyond 5 Years
por: Izano, Monika A., et al.
Publicado: (2020)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
por: Yang, Huan, et al.
Publicado: (2020)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study
por: Stanley, Adrian J, et al.
Publicado: (2017)

Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort
por: Kim, Seo Young, et al.
Publicado: (2011)

The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women
por: Rouach, Vanessa, et al.
Publicado: (2018)

Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates
por: Jeong, Ho-Gul, et al.
Publicado: (2017)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_8gk0nbuq8v4dtapbbk43el7vgt